| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 46 |
mPEG-NHS,MW:5000,末端N-羟基琥珀酰亚胺活性聚乙二醇 |
35 |
axc |
2025-12-30 |
| 47 |
ICG,吲哚菁绿,CAS:3599-32-4,成分与性质 |
42 |
axc |
2025-12-30 |
| 48 |
ICG MAL,吲哚菁绿-巯基活性衍生物的化学组成 |
33 |
axc |
2025-12-30 |
| 49 |
Gold Nanoparticles,Au(20nm)0.05mg/ml,金纳米颗粒 |
41 |
axc |
2025-12-30 |
| 50 |
G0-C14,十四烷基G0代代枝状聚合物的应用方向 |
36 |
axc |
2025-12-30 |
| 51 |
FITC-SH,荧光异硫氰酸硫醇的化学特性 |
29 |
axc |
2025-12-30 |
| 52 |
FITC-OVA,荧光异硫氰酸标记鸡卵白蛋白的物理性质 |
39 |
axc |
2025-12-30 |
| 53 |
FITC-L-谷氨酰胺,FITC-L-Glutamine ,定义与特点 |
34 |
axc |
2025-12-30 |
| 54 |
透明质酸(HA)修饰的超顺磁性Fe3O4纳米颗粒与阿霉素(DOX)形成复合物纳米粒,DOX-HA-MSNs |
57 |
YFF |
2025-12-30 |
| 55 |
荧光素-聚乙二醇-活化脂(FITC-PEG-NHS),荧光素-聚乙二醇-琥珀酰亚胺酯 |
73 |
HLL |
2025-12-29 |
| 56 |
α-Bungarotoxin-AF430,α-银环蛇毒素-AF 430 标记物 |
54 |
HLL |
2025-12-29 |
| 57 |
tri-GalNAc-己胺,三臂 N-乙酰半乳糖胺-己胺 |
42 |
HLL |
2025-12-29 |
| 58 |
AF532标记的α-Bungarotoxin,α-银环蛇毒素-AF 532 标记物 |
42 |
HLL |
2025-12-29 |
| 59 |
mPEG-DMG,甲氧基聚乙二醇-二肉豆蔻酰基甘油 |
44 |
HLL |
2025-12-29 |
| 60 |
tri-GalNAc,三臂 N-乙酰半乳糖胺 |
52 |
HLL |
2025-12-29 |
| 61 |
H2N-PEG-NH2,氨基-聚乙二醇-氨基 |
56 |
HLL |
2025-12-29 |
| 62 |
Tri-GalNAc-COOH,三臂 N-乙酰半乳糖胺-羧酸 |
41 |
HLL |
2025-12-29 |
| 63 |
DSPE-PEG-Cy5,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-花青 5 |
40 |
HLL |
2025-12-29 |
| 64 |
Tri-GalNAc(OAc)3-PFP ester,三乙酰化 N-乙酰半乳糖胺-五氟苯酯 |
29 |
HLL |
2025-12-29 |
| 65 |
DMG-PEG-Mal,二肉豆蔻酰基甘油-聚乙二醇-马来酰亚胺 |
28 |
HLL |
2025-12-29 |
| 66 |
Tri-GalNAc-NH2,三臂 N-乙酰半乳糖胺-氨基 |
22 |
HLL |
2025-12-29 |
| 67 |
mPEG-COOH,甲氧基聚乙二醇-羧基 |
29 |
HLL |
2025-12-29 |
| 68 |
DSPE-PEG-FA,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-叶酸 |
33 |
HLL |
2025-12-29 |
| 69 |
mPEG-Biotin,甲氧基聚乙二醇-生物素 |
22 |
HLL |
2025-12-29 |
| 70 |
α-Bungarotoxin-AF546 复合物,α-银环蛇毒素-AF 546 标记复合物 |
29 |
HLL |
2025-12-29 |
| 71 |
α-Bungarotoxin-AF568,α-银环蛇毒素-AF 568 标记物 |
27 |
HLL |
2025-12-29 |
| 72 |
mPEG-Acrylate(mPEG-AC),甲氧基聚乙二醇-丙烯酸酯 |
23 |
HLL |
2025-12-29 |
| 73 |
mPEG8-thiol,甲氧基聚乙二醇 8-巯基 |
33 |
HLL |
2025-12-29 |
| 74 |
DBCO-PEG-NHS Ester,二苯并环辛炔-聚乙二醇-琥珀酰亚胺酯 |
29 |
HLL |
2025-12-29 |
| 75 |
NOTA-琥珀酰亚胺酯,1,4,7-三氮杂环壬烷-1,4,7-三乙酸-琥珀酰亚胺酯 |
30 |
HLL |
2025-12-29 |
| 76 |
NODAGA-NHS(NODA-GA-NHS ester),1,4,7-三氮杂环壬烷-1-乙酸-4,7-二乙酸-琥珀酰亚胺酯 |
30 |
HLL |
2025-12-29 |
| 77 |
Acid-PEG-acid(HOOC-PEG-COOH),羧酸-聚乙二醇-羧酸 |
29 |
HLL |
2025-12-29 |
| 78 |
Vipivotide tetraxetan,维匹妥肽四氮杂环十四烷 |
28 |
HLL |
2025-12-29 |
| 79 |
FAPI-4,成纤维细胞活化蛋白抑制剂-4 |
27 |
HLL |
2025-12-29 |
| 80 |
DF-PEG-DF,苯甲醛聚乙二醇苯甲醛 |
29 |
HLL |
2025-12-29 |
| 81 |
Dopamine-PEG-Acetic Acid,多巴胺-聚乙二醇-乙酸 |
27 |
HLL |
2025-12-29 |
| 82 |
Dopamine-PEG-N3,多巴胺-聚乙二醇-叠氮基 |
29 |
HLL |
2025-12-29 |
| 83 |
DSPE-PEG-AMIDE-C3-NH₂,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-酰胺-C3-氨基 |
31 |
HLL |
2025-12-29 |
| 84 |
mPEG-琥珀酰亚胺戊酸酯,mPEG-SVA,甲氧基聚乙二醇-琥珀酰亚胺戊酸酯 |
35 |
HLL |
2025-12-29 |
| 85 |
基于腙键偶联的蚕丝胶蛋白纳米颗粒包载多柔比星和吲哚菁绿,DOX/ICG@Silk Sericin NPs-HZ |
53 |
YFF |
2025-12-29 |
| 86 |
透明质酸修饰负载表没食子儿茶素没食子酸酯的β-环糊精纳米颗粒,HA-β-CD@EGCG |
54 |
YFF |
2025-12-29 |
| 87 |
透明质酸修饰负载甲氨蝶呤与siRNA的LDH纳米载体,HA-LDH NPs@FITC/MTX/siRNA的结构 |
57 |
YFF |
2025-12-29 |
| 88 |
TechnoDye 502/512 |
47 |
kx |
2025-12-29 |
| 89 |
四嗪氨基Tetrazine,1092689-33-2广泛用于抗体药物偶联及生物分子修饰 |
44 |
hyy |
2025-12-29 |
| 90 |
融合蛋白肽CREKA兼具靶向性、成像能力和基因递送能力 |
44 |
hyy |
2025-12-29 |